Catheter ablation and left ventricular recovery in patients with clinically diagnosed polymorphic ventricular tachycardia and heart failure: a retrospective cohort study
Frontiers in Cardiovascular Medicine · 18.11.2026 · 13
DOI: 10.3389/fcvm.2026.2014842 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 18.11.2026. Verfasst von Qian Feng und 2 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Left ventricular recovery is an important treatment objective in patients with polymorphic ventricular tachycardia (PMVT) and heart failure. We examined 6-month left ventricular ejection fraction (LVEF) after radiofrequency catheter ablation (RFCA) in a retrospective cohort with paired cardiac magnetic resonance (CMR) measurements.
Methods
This single-center cohort included 92 patients with a clinical PMVT diagnosis and heart failure; 53 received RFCA and 39 did not. The primary outcome was baseline-adjusted 6-month LVEF. Propensity-score overlap weighting included 18 baseline covariates. HC3 standard errors, 2,000 treatment-stratified bootstrap resamples, reduced and expanded covariate sets, and ridge regularization assessed estimate stability. Native T1, extracellular volume fraction (ECV), premature ventricular complex (PVC) burden, biomarkers, and clinical events were secondary or exploratory outcomes.
Results
LVEF increased by 6.73 ± 2.15 percentage points with RFCA and 2.80 ± 1.86 without RFCA. The adjusted between-group difference was 3.70 percentage points (95% CI, 2.71–4.70); the propensity-refitting bootstrap interval was 2.78–4.53. Estimates incorporating hypertension and mineralocorticoid receptor antagonist use or ridge regularization ranged from 3.68 to 3.74 percentage points. Adjusted differences were −16.48 ms (95% CI, −20.44 to −12.53) for native T1, −1.26 percentage points (95% CI, −1.54 to −0.99) for ECV, and −6.77 percentage points (95% CI, −8.02 to −5.51) for PVC burden (all P < 0.001). Ventricular arrhythmia recurrence occurred in 5/53 vs. 10/39 patients; each group had two recurrences after the day-210 landmark.
Conclusions
RFCA was associated with greater 6-month LVEF recovery and lower recorded mapping indices and PVC burden in this selected paired-CMR cohort. Clinical-event comparisons were descriptive. The retrospective design, treatment selection, and requirement for paired CMR restrict the interpretation of these associations.
Zitieren
APA
Feng, Q., Zhao, D., & Cheng, W. (2026). Catheter ablation and left ventricular recovery in patients with clinically diagnosed polymorphic ventricular tachycardia and heart failure: a retrospective cohort study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.2014842
Vancouver
Feng Q, Zhao D, Cheng W. Catheter ablation and left ventricular recovery in patients with clinically diagnosed polymorphic ventricular tachycardia and heart failure: a retrospective cohort study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.2014842
BibTeX
@article{Feng2026,
author = {Feng, Qian and Zhao, Dongpo and Cheng, Wanhua},
title = {Catheter ablation and left ventricular recovery in patients with clinically diagnosed polymorphic ventricular tachycardia and heart failure: a retrospective cohort study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.2014842}
}
EUVIMED